Allas, Soraya
31  results:
Search for persons X
?
3

SAT237 AZP-3601, A Novel PTH 1 Receptor Agonist, Induces Ra..:

Figueres, Lucile ; Takacs, Istvan ; Mezosi, Emese...
Journal of the Endocrine Society.  7 (2023)  Supplement_1 - p. , 2023
 
?
4

OR23-04 Treatment Of Chronic Hypoparathyroidism With Enebop..:

Kamenicky, Peter ; Takacs, Istvan ; Mezosi, Emese...
Journal of the Endocrine Society.  7 (2023)  Supplement_1 - p. , 2023
 
?
 
?
6

LBODP094 Living With An "Invisible Disease": A Qualitative ..:

Crawford, Rebecca ; Allas, Soraya ; Tremel, Nadège...
Journal of the Endocrine Society.  6 (2022)  Supplement_1 - p. A738-A739 , 2022
 
?
7

Clinical Burden and Practice Patterns in Patients With Chro..:

Sharma, Dolly ; Deering, Kathleen L ; Loustau, Patrick...
Journal of the Endocrine Society.  5 (2021)  Supplement_1 - p. A259-A260 , 2021
 
?
8

Clinical Burden and Practice Patterns in Patients With Chro..:

Sharma, Dolly ; Deering, Kathleen L ; Loustau, Patrick...
Journal of the Endocrine Society.  5 (2021)  Supplement_1 - p. A259-A259 , 2021
 
?
9

A Single Administration of AZP-3601, a Novel, Long-Acting P..:

Allas, Soraya ; Ovize, Michel ; Culler, Michael D...
Journal of the Endocrine Society.  5 (2021)  Supplement_1 - p. A254-A254 , 2021
 
?
10

SUN-609 Livoletide (AZP-531), an Unacylated Ghrelin Analogu..:

Allas, Soraya ; Yeh, Michael ; Delale, Thomas.
Journal of the Endocrine Society.  4 (2020)  Supplement_1 - p. , 2020
 
?
11

MON-102 Nonclinical Development of AZP-531 (Livoletide): A ..:

Milano, Stephane ; Allas, Soraya ; Cade, Didier..
Journal of the Endocrine Society.  3 (2019)  Supplement_1 - p. , 2019
 
?
12

SAT-100 Trial-in-Progress: ZEPHYR, a Pivotal Phase 2b/3 Ran..:

Allas, Soraya ; Mohideen, Pharis ; Delale, Thomas...
Journal of the Endocrine Society.  3 (2019)  Supplement_1 - p. , 2019
 
1-15